SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000882104-18-000114
Filing Date
2018-11-06
Accepted
2018-11-06 16:08:06
Documents
16
Period of Report
2018-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pdli-201811068xkdoc.htm 8-K 37406
2 PRESS RELEASE pdli-201811068xkex991.htm EX-99.1 247778
3 PRESENTATION pdli-201811068xkex992.htm EX-99.2 5519
4 INFORMATION SHEET pdli-201811068xkex993.htm EX-99.3 224538
5 pdllogoa11.jpg GRAPHIC 123123
6 slide1a79.jpg GRAPHIC 48078
7 slide2a79.jpg GRAPHIC 217009
8 slide3a79.jpg GRAPHIC 146482
9 slide4a79.jpg GRAPHIC 128290
10 slide5a79.jpg GRAPHIC 121620
11 slide6a79.jpg GRAPHIC 122548
12 slide7a79.jpg GRAPHIC 152900
13 slide8a77.jpg GRAPHIC 85381
14 slide9a76.jpg GRAPHIC 174521
15 slids95.jpg GRAPHIC 115840
16 slids96.jpg GRAPHIC 107338
  Complete submission text file 0000882104-18-000114.txt   2642795
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 181163036
SIC: 2836 Biological Products, (No Diagnostic Substances)